There has been concern that Medicare’s “quality” improvement programs–readmission reductions, hospital-acquired conditions elimination, value-based purchasing–have a disproportionate impact on some hospitals, especially those that serve more poor communities and patients. Teaching hospitals are generally affiliated with medical schools and while they often have a reputation for high-quality, they also can score poorly in these programs, and that may be because of the patient populations they treat. A report from an organization representing the colleges, the Association of American Medical Colleges, issues a report indicating the negative revenue impact these programs are having on teaching institutions. (AAMC Report) There are 302 major teaching hospitals; up to 5.5% of their base Medicare revenues are at risk. And for these teaching hospitals, losing revenue is a reality–90% are penalized under the readmissions program, 50% under the acquired-conditions one and 60% under value-based purchasing. Since many of these hospitals have more quality accreditations and perform better on clinical process and outcome measures, there is a serious disjunct somewhere. The researchers divided teaching hospitals into quintiles according to payment adjustments under the programs and looked to see if there were correlations across various factors. The most important correlation was with socio-economic status; hospitals serving more poor patients were more likely to be penalized. This was far and away the most explanatory variable among those examined. The only other one that had even modest explanatory power was teaching intensity–the number of interns per bed. The study once again demonstrates that there are serious flaws in Medicare’s quality programs and that the hospitals which treat more poor people, and need more resources to treat them, are being hurt by the failure to make appropriate adjustments in how performance is calculated.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
In truth, this seems like more money down a rathole. Google’s parent and other investors are putting a billion dollars into Google’s health arm, Verily. Apparently want to compete with...
September 12, 2022
It is like investors have learned nothing from the past two years. Even supposedly smart investors like Morgan Health, which is making a $20 million contribution to LetsGetChecked, which supposedly...
September 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace